Jiangsu Jibeier Pharmaceutical Co., Ltd.
SHH: 688566.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Zhongyi Geng
- Employees
- 1,327
- Headquarters
- Zhenjiang, China
- IPO year
- 2020
- Market cap
- CN¥5.6B
- Website
- https://www.jibeier.com.cn
Loading 688566…
Loading profile data…Frequently asked questions about 688566
What does Jiangsu Jibeier Pharmaceutical Co., Ltd. (688566.SS) do?
Jiangsu Jibeier Pharmaceutical Co., Ltd., a pharmaceutical company, engages in the research, development, production, and sale of chemical preparations, proprietary Chinese medicine preparations, and bulk medicines. The company's products cover various therapeutic areas, such as improving white blood cells, enhancing immunity, treating joint dis...
Where does 688566.SS trade?
Jiangsu Jibeier Pharmaceutical Co., Ltd. (688566.SS) trades on the Shanghai Stock Exchange.
What sector is 688566.SS in?
Jiangsu Jibeier Pharmaceutical Co., Ltd. (688566.SS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Jiangsu Jibeier Pharmaceutical Co., Ltd.?
Zhongyi Geng is the chief executive officer of Jiangsu Jibeier Pharmaceutical Co., Ltd. (688566.SS).
Where is Jiangsu Jibeier Pharmaceutical Co., Ltd. headquartered?
Jiangsu Jibeier Pharmaceutical Co., Ltd. is headquartered in China.
Does 688566.SS pay a dividend?
Yes — Jiangsu Jibeier Pharmaceutical Co., Ltd. (688566.SS) paid a trailing twelve-month dividend of CNY 0.52 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 688566.SS go public?
Jiangsu Jibeier Pharmaceutical Co., Ltd. (688566.SS) completed its initial public offering in 2020.